Table 4 Antimicrobial potential of the most active phytoconstituents of Symplocos racemosa bark against drug- resistant strains and some clinical isolates of MRSA

CRIRS 1

15.33 ± 0.881

–

CRIRS 2

15.66 ± 0.333

–

CRIRS 3

16 ± 0.577

–

CRIRS 4

17.33 ± 0.333^a

14.66 ± 0.333^b

CRIRS 5

17 ± 0.577 ^a

12.33 ± 0.333^b

CRIRS 6

16.66 ± 0.333^a

13 ± 0^b

CRIRS 7

22.66 ± 0.666

–

Group 1

CRIRS 8

17.66 ± 0.333^a

13.66 ± 0.333^b

CRIRS 9

14.66 ± 0.881

–

CRIRS 10

15.33 ± 0.881^a

14.33 ± 0.333^a

CRIRS 11

15 ± 0.577

–

CRIRS 12

15.66 ± 0.666

–

CRIRS 13

19.66 ± 0.333^a

14 ± 0^b

CRIRS 14

18.66 ± 0.333

–

CRIRS 15

14.66 ± 0.333

–

CRIRS 16

16.33 ± 0.881

–

CRIRS 17

20 ± 0

–

CRIRS 18

19.33 ± 0.333

–

CRIRS 19

16 ± 0

–

CRIRS 20

15.33 ± 0.333

–

CRIRS 21

17.66 ± 0.333

–

CRIRS 22

18.66 ± 0.333

–

DSECI 01

21.33 ± 0.333^a

14 ± 0^b

DSECI 02

20 ± 0^a

17.33 ± 0.666^b

DSECI 03

27.66 ± 0.333^a

16.66 ± 0.881^b

DSECI 04

28.33 ± 0.333^a

18 ± 0 ^b

Group 2

DSECI 05

24.33 ± 0.666^a

15 ± 0 ^b

DSECI 06

22.33 ± 0.333^a

14.33 ± 0.333^b

DSECI 07

26.33 ± 0.666

–

DSECI 08

22 ± 0.577^a

14.33 ± 0.666^b

DSECI 09

25.66 ± 0.333

–

DSECI 10

27.33 ± 0.333

–

DSECI 11

–

–

DSECI 12

23.33 ± 0.333^a

15.66 ± 0.333^b